Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 10—October 2021
Online Report

Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, February–June 2020

Tomoya SaitoComments to Author , Kaori Muto, Mikihito Tanaka, Nobuhiko Okabe, Hitoshi Oshitani, Satoshi Kamayachi, Yoshihiro Kawaoka, Akihiko Kawana, Motoi Suzuki, Kazuhiro Tateda, Hitomi Nakayama, Masaki Yoshida, Akifumi Imamura, Fumio Ohtake, Norio Ohmagari, Ken Osaka, Mitsuo Kaku, Tomimasa Sunagawa, Kazutoshi Nakashima, Hiroshi Nishiura, Koji Wada, Shigeru Omi, and Takaji Wakita
Author affiliations: National Institute of Infectious Diseases, Tokyo, Japan (T. Saito, M. Suzuki, T. Sunagawa, T. Wakita); Institute of Medical Science, The University of Tokyo, Tokyo (K. Muto, Y. Kawaoka); Waseda University Graduate School of Political Science, Tokyo (M. Tanaka); Kawasaki City Institute for Public Health, Kawasaki, Japan (N. Okabe); Tohoku University Graduate School of Medicine, Sendai, Japan (H. Oshitani); Japan Medical Association, Tokyo (S. Kamayachi); University of Wisconsin–Madison, Madison, Wisconsin, USA (Y. Kawaoka); National Defense Medical College, Tokorozawa, Japan (A. Kawana); Toho University School of Medicine, Tokyo (K. Tateda); Kasumigaseki–Sogo Law Office, Tokyo (H. Nakayama); Jikei University School of Medicine, Tokyo (M. Yoshida); Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo (A. Imamura); Osaka University Graduate School of Economics, Toyonaka, Japan (F. Ohtake); National Center for Global Health and Medicine, Tokyo (N. Ohmagari); Tohoku University Graduate School of Dentistry, Sendai (K. Osaka); Tohoku Medical and Pharmaceutical University, Sendai (M. Kaku); Daito Bunka University, Higashimatsuyama, Japan (K. Nakashima); Graduate School of Medicine and Faculty of Medicine Kyoto University, Kyoto, Japan (H. Nishiura); International University of Health and Welfare, Narita, Japan (K. Wada); Japan Community Health Care Organization, Tokyo (S. Omi)

Main Article

Table 1

Agenda of the Advisory Board for the Minster of Health, Labour, and Welfare regarding COVID-19 in Japan, February 2020

Meeting no. Date Agenda
1 Feb 7 Intervention strategy for a cruise ship outbreak, testing policy for asymptomatic cases, infectivity and pathogenicity of SARS-CoV-2
2 Feb 10 Intervention strategy for a cruise ship outbreak, testing policy for detecting cases,
infectivity and virulence of COVID-19, infectivity of asymptomatic cases, risk for virus mutation

*COVID-19, coronavirus disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Main Article

Page created: August 18, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external